CLOV vs OSCR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

CLOV

34.3
AI Score
VS
OSCR Wins

OSCR

41.0
AI Score

Investment Advisor Scores

CLOV

34score
Recommendation
SELL

OSCR

41score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CLOV OSCR Winner
Forward P/E 81.9672 588.2353 CLOV
PEG Ratio 0 0 Tie
Revenue Growth 55.6% 70.4% OSCR
Earnings Growth 0.0% 125.6% OSCR
Tradestie Score 34.3/100 41.0/100 OSCR
Profit Margin -0.7% 3.6% OSCR
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD OSCR

Relative Price Performance (Last 90 Days)

CLOV 1M: +0.0% · 3M: +1.2% OSCR 1M: -1.7% · 3M: +34.6%

Current Technical Phase

CLOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.0 · Price: $4.23

OSCR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.2 · Price: $30.05

Fundamentals Snapshot

Metric CLOV OSCR
Market Cap
Forward P/E 28.2 16.0
Trailing P/E 23.8
Revenue (TTM)
Revenue Growth 0.6% 0.7%
Gross Margin 0.2% 0.2%
Operating Margin 0.0% 0.1%
EPS -0.05 1.31
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, OSCR is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.